期刊文献+

1,5-二芳基吡唑类环氧合酶-1选择性抑制剂的CoMFA研究 被引量:3

The COMFA study on 1,5-diarylpyrazole class of cyclooxygenase-2 selective inhibitors
原文传递
导出
摘要 目的:应用比较分子力场法(CoMFA)研究一系列1,5-二芳基吡唑类对环氧合酶-1选择性抑制剂三维定量构效关系,为进一步药物设计提供理论依据.方法和结果:在研究的14个化合物中,用比较分子力场法得到1个CoMFA模型,交叉验证系数q2为0.818,具有较高的预测能力及合理性,非交叉验证模型相关系数r2为0.958,标准偏差为0.077,F为79.834;并依据模型设计,预测了几个具有较高活性的化合物.结论:此模型对设计和预测高活性的1,5-二芳基吡唑类环氧合酶-1选择性抑制剂有一定可靠性. CoMFA ( comparative molecular field analysis) models of the 1,5-diarylpyrazoles of cyclooxygenase -1 selective in hibitors was established using the advanced 3D-QSAR method in order to give a theoretical basis to design new inhibitors. The crossvalidated coefficinet q^2 of one model reached 0. 818, the non-crossvalidated coefficient r^2 was 0. 958, the standard deviation was 0. 077 and F was 79. 834. The CoMFA models of 1,5- diarylpyraxoles reveal the relationship between COX-1 bioactivity and structure, and are helpful to further design new inhibitors with hight bioactivity.
出处 《云南大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第5期429-433,共5页 Journal of Yunnan University(Natural Sciences Edition)
基金 中国科学院昆明植物研究所植物化学与西部植物资源持续利用国家重点实验室基金资助
关键词 比较分子力场法(CoMFA) 1 5-二芳基吡唑类环 环氧合酶-1选择性抑制剂 CoMFA 1,5-diarylpyrazoles cyclooxygenase-1 selective inhibitors
  • 相关文献

参考文献11

  • 1VILLEGAS I,Alarcon De La Lastra C,MARTIN M J,et al.Gastric damage induced by subchronic administration of preferential cyclooxygenase - 1 and cyclooxygenase - 2 inhibitors in rats[J]. Pharmacology, 2002,66( 2 ): 68-75.
  • 2CIPOLLA G, CREMA F, SACCO S, et al. Nonsteroidal antiinflammatory drugs and inflammatory bowel disease: Current perspectives[J]. Pharmacol Res, 2002,46( 1 ): 1 -6.
  • 3XIE W, CHIPMAN J G, ROBERTSON D L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is trgulated by mRNA splicing[J]. Proc Natl Acad Sci USA,1991,88(6) :2 692-2 696.
  • 4GILROY D W, Colville-Nash P H, WILLIS D, et al. Inducible cyclooxygenase may have anti-inflammatory properties[J]. Nat Med, 1999,5: 698-701.
  • 5CRYER B. Mucosal defense and repair. Role of prostaglandins in the stomach and duodenum[J]. Gastroenterol Clin North Am,2001,30:877-894.
  • 6SUGIMOTO Y, NARUMIYA S, ICHIKAWA A. Distribution and function of prostanoid receptors: studies from knockout mice[J] .Prog Lipid Res,2000,39: 289-314.
  • 7张邦乐,梅其炳,周四元,何炜,陈长生.1,5-二芳基吡唑类环加氧酶-2选择性抑制剂的定量构效关系[J].第四军医大学学报,2003,24(16):1523-1525. 被引量:5
  • 8PENNING T D,TALLEY J J,BERTENSHAW S R.Synthesis and biological evaluation of the 1,5 - diarylpyrazole class of cyclooxygenase - 2 inhibitors [J]. J Med Chem, 1997, 40(9): 1 347-1 365.
  • 9顾云兰,李宝宗.2-苯基吲哚衍生物的定量结构-活性关系研究[J].云南大学学报(自然科学版),2004,26(3):241-244. 被引量:6
  • 10李涛洪 宋仲容 潘蓄林.槲皮素抗氧化活性构效关系的DFT研究[J].云南大学学报:自然科学版,2004,26(5):46-50.

二级参考文献22

  • 1杨光富,陈琼,张莉.Phytocassane衍生物的电子结构特征及构效关系研究[J].计算机与应用化学,2002(5):571-574. 被引量:4
  • 2[1]Villegas I, Alarcon De La Lastra C, Martin MJ, Motilva V, La Casa Garcia C. Gastric damage induced by subchronic administration of preferential cyclooxygenase-1 and cyclooxygenase-2 inhibitors in rats [J]. Pharmacology, 2002;66(2):68-75.
  • 3[2]Cipolla G, Crema F, Sacco S, Moro E, De Ponti F, Frigo G. Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: Current perspectives [J]. Pharmacol Res, 2002;46(1):1-6.
  • 4[3]Xie W, Chipman JG, Robertson DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing [J]. Proc Natl Acad Sci USA, 1991;88(6):2692-2696.
  • 5[4]Luong C, Miler A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID blinding site in the structure of human cyclooxygenase-2 [J]. Nat Strut Biol, 1996;3:927-933.
  • 6[5]Selinsky BS, Gupta K, Sharkey CT, Loll PJ. Structural analysis of NSAID binding by prostaglandin H2 synthase: Time-dependent and time-independent inhibitors elicit identical enzyme conformations [J]. Biochemistry, 2001;40(17):5172-5180.
  • 7[6]Kothekar V, Sahi S, Srinivasan M, Mohan A, Mishra J. Recognition of cyclooxygenase-2 (COX-2) active site by NSAIDs: A computer modelling study [J]. Indian J Biochem Biophys, 2001;38(1-2):56-63.
  • 8[7]Penning TD, Talley JJ, Bertenshaw SR. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors [J]. J Med Chem, 1997;40(9):1347-1365.
  • 9[8]Wang LS, Zhi ZL. Molecular connectivity index and molecular structure activity [M]. First edition. Bejing: Chinese Environment Science Press, 1992:107-108.
  • 10[9]Picot D, Loll PJ, Garavito RM. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 [J]. Nature, 1994;367:243-249.

共引文献10

同被引文献49

  • 1黄国军,黄新友.钛酸锶钡粉体制备方法研究进展[J].兵器材料科学与工程,2005,28(6):69-72. 被引量:6
  • 2易平,闵勇,古昆,邱明华.硝基呋喃铵类化合物抗肺结核活性的CoMFA研究[J].云南大学学报(自然科学版),2006,28(1):54-59. 被引量:2
  • 3臧军,曾燕伟,孔祥蓉,董彪.功能氧化物纳米晶的液相法制备[J].材料导报,2006,20(F05):34-37. 被引量:2
  • 4李涛洪 宋仲容 潘蓄林.槲皮素抗氧化活性构效关系的DFT研究[J].云南大学学报:自然科学版,2004,26(5):46-50.
  • 5王传铭 潘蓄林 李涛洪.新霉素B的结构特征及其与HIV—1RRE结合能力的关系[J].云南大学学报:自然科学版,2004,26(5):100-104.
  • 6DYE C, SCHEELE S, DOLIN P, et al. Global burden of tuberculosis. Estimated Incidence, Prevalence, and Mortality by Country[J]. J Am Med Assoe, 1999, 282(7):677-686.
  • 7MURRAY J F. Tuberculosis and HIV infection: a global perspective[J]. Respiration, 1998, 65(5) :335-342.
  • 8SCHRAUFNAGEL D, ABUBAKER J. Global action against multidrug-resistant tuberculosis[J]. J Am Med Assoc, 2000, 283(1) :54.
  • 9PORTAELS F, RIGOUTS L, BASTIAN I. Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former soviet union[J]. Int J Tubere Lung D, 1999, 3(7) :582-588.
  • 10BURMAN W J, JONES B E. Treatment of HW-related tuberculosis in the era of effective antiretroviral therapy[J]. Am J Respir Crit Care Med, 2001,164:7-12.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部